KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Revenue (2016 - 2026)

Medtronic (MDT) has disclosed Revenue for 13 consecutive years, with $9.0 billion as the latest value for Q1 2026.

  • Quarterly Revenue rose 8.74% to $9.0 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $35.5 billion through Jan 2026, up 6.88% year-over-year, with the annual reading at $33.5 billion for FY2025, 3.62% up from the prior year.
  • Revenue hit $9.0 billion in Q1 2026 for Medtronic, up from $9.0 billion in the prior quarter.
  • In the past five years, Revenue ranged from a high of $9.0 billion in Q1 2026 to a low of $7.4 billion in Q3 2022.
  • Historically, Revenue has averaged $8.2 billion across 5 years, with a median of $8.1 billion in 2022.
  • Biggest five-year swings in Revenue: fell 7.71% in 2022 and later increased 8.74% in 2026.
  • Year by year, Revenue stood at $7.6 billion in 2022, then grew by 5.26% to $8.0 billion in 2023, then grew by 5.25% to $8.4 billion in 2024, then increased by 6.64% to $9.0 billion in 2025, then increased by 0.62% to $9.0 billion in 2026.
  • Business Quant data shows Revenue for MDT at $9.0 billion in Q1 2026, $9.0 billion in Q4 2025, and $8.6 billion in Q3 2025.